Call For Research Papers 2011

International Journal of Scientific and Research Publications
International Journal of Scientific and Research Publication (IJSRP) is a quality publication of peer reviewed and refereed international journals from diverse fields in sciences, engineering and technologies that emphasizes new research, development and their applications.

IJSRP publishes online journal with ISSN 2250-3153

IJSRP provides an open access forum for scientists, scholars, researchers and engineers to exchange their research work, technical notes & surveying results among professionals through out the world in e-journals or print publications.
e-journal: IJSRP being a part of eco friendly community promotes the e-publication mode by publishing all it's journals through monthly subscription of IJSRP e-journal.

Online Submission
Subscribe
Indexing Partners
Publication Certificate
Conference Papers
Print journal: IJSRP facilitates the widespread of information to institutional bodies by providing the online print version of journals.

Being an online journal, IJSRP does not provide hard copy of monthly subscription and promotes minimal print of the online content.

Call for Papers (APRIL 2018):

All researchers are invited to submit their original papers for peer review and publications. Before submitting papers at IJSRP the authors must ensure that their works in original or refereed form have never published anywhere and be agreed upon the entire fraternity of authors. The authors must also agree and adhere on originality and authenticity of their research work.

Written manuscript along with abstract in IJSRP Format should be submitted via email at editor@ijsrp.org.

You can find more details at

Online Submission

.

IJSRP review and publish:
  • Research Paper
  • Case Studies
  • Analytical papers
  • Review Article
  • Argumentative papers
  • Survey research and data analysis
We provide DOI number to papers after publication.


IJSRP invites authors form internationally top ranked research institutes, universities to publish their Dissertation or Thesis work. Partial publication cost should bear by individual or institute and 50% will be funded by IJSRP.

Authors can publish their research in form of Monograph or Thesis.

Submit Thesis/Monograph








IJSRP index partners include BASE (Bielefeld University Library), Google Scholar, Citeseer and others. We have our own research library (OARD) based on OAI-PMH.

Open Access Research Database (OARD): IJSRP maintains all published papers in OARD which provides open access to listed papers among universities, researchers and scholars. OARD is based on OAI-PMH (Open Archives Initiative Protocol for Metadata Harvesting) protocols which help to index the research papers worldwide.











IJSRP Volume 8
March 2018 Edition[NEW]
February 2018 Edition
January 2018 Edition

IJSRP Volume 7
December 2017 Edition
November 2017 Edition
October 2017 Edition
September 2017 Edition
August 2017 Edition
July 2017 Edition
June 2017 Edition
May 2017 Edition
April 2017 Edition
March 2017 Edition
February 2017 Edition
January 2017 Edition

IJSRP Volume 6
December 2016 Edition
November 2016 Edition
October 2016 Edition
September 2016 Edition
August 2016 Edition
July 2016 Edition
June 2016 Edition
May 2016 Edition
April 2016 Edition
March 2016 Edition
February 2016 Edition
January 2016 Edition

IJSRP 2015, Volume 5 Issue
[12][11][10][9][8][7]
[6][5][4][3][2][1]

IJSRP 2014, Volume 4 Issue
[12][11][10][9][8][7]
[6][5][4][3][2][1]

IJSRP 2013, Volume 3 Issue
[12][11][10][9][8][7]
[6][5][4][3][2][1]

IJSRP 2012, Volume 2 Issue
[12][11][10][9][8][7]
[6][5][4][3][2][1]

IJSRP 2011, Volume 1 Issue
[1]
   

Pharmacological Research publishes cutting-edge articles in biomedical sciences to cover a broad range of topics that move the pharmacological field forward. We provide a venue through which specialists across disciplines can rapidly exchange information in health sciences that pertains to modern pharmacological topics. The journal publishes articles on molecular, biochemical, translational, and clinical research (including clinical trials); it is proud of its rapid publication of accepted papers that comprises a dedicated, fast acceptance and publication track for high profile articles.

Invited and unsolicited review articles are welcome.

Journal Sections
Specific sections are dedicated to:

The cardiovascular system:

  • CV disease therapy;
  • Signal transduction and receptor pharmacology in the CV system;
  • Target organs;
  • Clinical trials.

Neuroscience, including psychopharmacology, and neuroendocrinology:

  • Understanding of the central nervous system in physiological and pathological conditions;
  • Neuropharmacological and molecular mechanisms of learning and memory;
  • Therapeutic and diagnostic challenges for mental illness and neurodegerative diseases;
  • System biology.

Oncology:

  • Targeted cancer therapy;
  • Precision medicine and personalized therapy;
  • Signal transduction studies, as related to drug action;
  • Clinical trials.

Immunology (clinical and basic):

  • Immune and inflammatory mechanisms including target identification;
  • Immunotherapy and immunotoxicology;
  • Immunopathology;
  • Vaccines and adjuvants;
  • Treatment of infectious diseases.

Pharmacogenomics, Pharmacogenetics and Precision Medicine:

  • We are especially interested in GWAS studies and studies reporting pharmacogenetic data that are relevant in terms of safety and efficacy of drugs. They must provide insight into novel genomic or therapeutic associations that can help guide therapy selection or suggest new indications for established drugs. Studies can also provide details of exceptional responses in limited numbers of patients.
  • We also publish n=1 studies of exceptional responses, provided they are backed up by compelling genomic or experimental data.
  • Studies must include full clinical description of the case, along with details of the response and supporting molecular information. The molecular information should support the clinical observations and offer a definitive pharmacogenomic insight. Standard clinical sequencing assays (Foundation ONE, Genoptix etc) are only appropriate when the therapeutic or phenotypic response is novel. Ideally, the observational patient studies should be supported by lab based functional data.

Bioactive molecules derived from medicinal plants or natural products:

  • New, effective bioactive molecules;
  • Drug target identification;
  • Treatment mechanism;
  • Mechanism investigation with -omics and computational technologies;
  • Combinational therapy with natural products;
  • Multi-targeting and network pharmacology;
  • Herbal bioinformatics;
  • Precision medicine of natural products;
  • Evidenced-based research and clinical trials.

Studies reporting on plant extracts in which the active principle(s) has not been defined do not fall into the scope of this journal. Exceptions can be made for papers addressing the mechanisms of actions or the clinical applications of standardized herbal preparations. Clinical studies on commercially-available nutraceuticals are also taken into consideration.

Rare diseases and orphan drugs, and drug repositioning

We also publish articles focusing on:

  • Gastrointestinal, respiratory and urogenital apparatuses when involving pharmacological issues;
  • Pharmacology of tissue repair/regeneration;
  • Pharmacology of aging;
  • Nutraceuticals (if relevant to human disease);
  • Pharmacoeconomy;
  • Pharmacoepidemiology.

We do not publish:

  • Papers reporting pharmacological activities of novel compounds if no proper controls with known substances are performed;
  • Bioequivalence studies or studies reporting only the pharmacokinetics profile of a compound;
  • Descriptive pharmacovigilance studies;
  • Single dose/concentration studies and those measuring only one endpoint.
Hide full Aims & Scope

One thought on “Call For Research Papers 2011

Leave a Reply

Your email address will not be published. Required fields are marked *